Advertisement

Topics

Dr. Reddy's fourth-quarter revenue climbs 14 percent, led by generic drug sales in emerging markets https://www.firstwordpharma.com/node/1641746 

08:52 EDT 17 May 2019 | FirstWord Pharma

Dr. Reddy's fourth-quarter revenue climbs 14 percent, led by generic drug sales in emerging markets https://www.firstwordpharma.com/node/1641746 

Original Article: Dr. Reddy's fourth-quarter revenue climbs 14 percent, led by generic drug sales in emerging markets https://www.firstwordpharma.com/node/1641746 

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's fourth-quarter revenue climbs 14 percent, led by generic drug sales in emerging markets https://www.firstwordpharma.com/node/1641746 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...